» Authors » Mey L Reytor

Mey L Reytor

Explore the profile of Mey L Reytor including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 23
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Cabrera-Munoz A, Sierra-Gomez Y, Covaleda-Cortes G, Reytor M, Gonzalez-Gonzalez Y, Bautista J, et al.
Mar Drugs . 2023 Feb; 21(2). PMID: 36827135
Metallocarboxypeptidases are zinc-dependent peptide-hydrolysing enzymes involved in several important physiological and pathological processes. They have been a target of growing interest in the search for natural or synthetic compound binders...
2.
Del Rivero M, Reytor M, Trejo S, Chavez M, Aviles F, Reverter D
Structure . 2013 Jun; 21(7):1118-26. PMID: 23746805
The crystal structure of SmCI (Sabellastarte magnifica carboxypeptidase inhibitor) has been determined in complex with human carboxypeptidase A4 (hCPA4). SmCI is composed by three BPTI/Kunitz domains, each one displaying high...
3.
Alonso-Del-Rivero M, Trejo S, Reytor M, Rodriguez-de-la-Vega M, Delfin J, Diaz J, et al.
J Biol Chem . 2012 Mar; 287(19):15427-38. PMID: 22411994
This study describes a novel bifunctional metallocarboxypeptidase and serine protease inhibitor (SmCI) isolated from the tentacle crown of the annelid Sabellastarte magnifica. SmCI is a 165-residue glycoprotein with a molecular...
4.
Penton D, Perez-Barzaga V, Diaz I, Reytor M, Campos J, Fando R, et al.
Protein Eng Des Sel . 2011 Feb; 24(6):485-93. PMID: 21296830
The use of pore-forming toxins from sea anemones (actinoporins) in the construction of immunotoxins (ITs) against tumour cells is an alternative for cancer therapy. However, the main disadvantage of actinoporin-based...